| Typicality: | 0.301 |
| Saliency: | 0.503 |
| regardless of | 8 | other |
| compared with placebo | 6 | other |
| more often | 5 | degree |
| improvement → be observed in → patient | 36 |
| improvement → be seen in → patient | 28 |
| improvement → be found in → patient | 6 |
| improvement → be noted in → patient | 5 |
| improvement → be demonstrated in → patient | 5 |
| improvement → be shown in → patient | 4 |
| negative | neutral | positive |
| 0.073 | 0.310 | 0.617 |
| Raw frequency | 84 |
| Normalized frequency | 0.503 |
| Modifier score | 0.265 |
| Perplexity | 194.938 |